Session 730: LC–MS—General Interest
This Monday afternoon session will be presided over by Eduard Rogatsky of the Wadsworth Center, DEHS.
Session 730
Room W176b, 1:30 pm
March 6 - Chicago, Illinois - This Monday afternoon session will be presided over by Eduard Rogatsky of the Wadsworth Center, DEHS.
The session will begin with a presentation by Eduard Rogatsky of the New York State Department of Health who will present “Development of High Throughput LC–MS/MS Method for Analysis of Perfluorooctanoic Acid from Serum, Suitable for Large-Scale Human Bio-Monitoring. Rogatsky’s presentation will focus on a simple method using a high-throughput sample preparation approach that should be advantageous for large-scale epidemiological or biomonitoring studies.
Following Rogatsky, Lei Cheng of Nalco Champion, an Ecolab Company, will present “Differentiation and Quantitation of Phosphonates Using Ion Chromatography and Triple Quadrupole Mass Spectrometry.” Cheng will discuss the development of a high sensitive and specific quantitation method for phosphates in an aqueous matrix by ion chromatography and triple-quadrupole mass spectrometry.
Robin Hendrikus Johannes Kemperman of the University of Florida will speak next on “Clinical Isomer Analysis in Blood Plasma with Ion Mobility–Mass Spectrometry.” This presentation will review several strategies that were developed to improve the ion mobility spectrometry separation of metabolites in blood plasma, with the goal of significantly reduced analysis time.
Yun Chen will follow Kemperman’s presentation with a “Quantitative Study of microRNAs by Immobilized DNA-Peptide Probe and Liquid Chromatography–Tandem Mass Spectrometry-Based Quasi-Targeted Proteomics.” Chen’s discussion will focus on the development of an LC–MS/MS-based quasi-targeted proteomics assay.
After a short recess, Yanhui Wang of the Ohio State University will give a talk on the “Separation of Metal Nanoparticles by Ultrathin Layer Chromatography Using Electrospun Nanofibers as the Stationary Phase.” The analytical performance of this method will be evaluated under optimized conditions.
Jason Kieltyka of Abbott Laboratories will speak next on “Sample Collection Tubes-A Preanalytical Factor that Can Influence Laboratory Developed In Vitro Diagnostic Tests.” Kieltyka will discuss the results of a customer comment that aliquot tubes from a specific source received unusual results from an LC–MS/MS laboratory developed test for 25OHD2/3.
Aviv Amirav from Tel Aviv University will follow with a presentation titled “LC–MS with Cold EI-The New System and Recent Applications.” The presentation will include a discussion about the development of a new electron ionization (EI) LC–MS system with cold EI based on an Agilent 5977 GC–MS system.
The final presentation will be given by Sonia Medina of Corporación Universitaria Lasallista. The presentation, titled “Agro-Industrial Residues from Physalis peruviana Calcyces as Natural Source of Phytoprostanes and Phenolic Compounds,” will focus on a study that has allowed increasing knowledge about the chemical composition of calyces of the Cape gooseberry or goldenberry and how it could support the valorization of a class of agro-industries residues.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
